Jan. 14 Financial Quick Takes: Schrödinger proposes NASDAQ IPO; plus Mirati, Blackstone, Orexia, Jasper, seqWell

Schrödinger seeking NASDAQ listing
Computational physics and drug discovery company Schrödinger Inc. proposed to raise up to $100 million in an IPO on NASDAQ. The company’s largest shareholders are the Bill and Melinda Gates Foundation and hedge fund operator David E. Shaw. According to its prospectus, Schrödinger has raised $192.6 million to date, including amounts received from its equity investment in Nimbus Therapeutics LLC; the company announced an $85 million series E round in early 2019 (see “Schrödinger Raises Series E”).

Mirati completes $345M follow-on
Cancer company Mirati Therapeutics Inc. (NASDAQ:MRTX) raised $345 million through the sale of 3.5 million shares at $97.50 in a follow-on, including an overallotment of shares sold to underwriters. The price is a 7% discount to Mirati’s closing price of $104.74 on Jan. 8, when it proposed after hours to raise $250 million. Mirati’s lead program targets K-Ras (KRAS). Underwriters are Goldman Sachs, SVB Leerink, Cowen, Credit Suisse and Jones Trading (see “Transforming Mirati’s Story”)...